[HTML][HTML] Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics

KR Wildsmith, SP Schauer, AM Smith, D Arnott… - Molecular …, 2014 - Springer
Background Alzheimer's disease (AD) is the leading cause of dementia affecting greater
than 26 million people worldwide. Although cerebrospinal fluid (CSF) levels of Aβ 42, tau …

[引用][C] Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics

KR Wildsmith, SP Schauer, AM Smith, D Arnott… - Molecular …, 2014 - cir.nii.ac.jp
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid
by targeted proteomics | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics

KR Wildsmith, SP Schauer… - Molecular …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Alzheimer's disease (AD) is the leading cause of dementia affecting greater
than 26 million people worldwide. Although cerebrospinal fluid (CSF) levels of Aβ42, tau …

Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics.

KR Wildsmith, SP Schauer, AM Smith… - Molecular …, 2014 - europepmc.org
Background Alzheimer's disease (AD) is the leading cause of dementia affecting greater
than 26 million people worldwide. Although cerebrospinal fluid (CSF) levels of Aβ42, tau …

Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics.

KR Wildsmith, SP Schauer, AM Smith… - Molecular …, 2014 - search.ebscohost.com
Background Alzheimer's disease (AD) is the leading cause of dementia affecting greater
than 26 million people worldwide. Although cerebrospinal fluid (CSF) levels of Aβ42, tau …

Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics

KR Wildsmith, SP Schauer, AM Smith… - Molecular …, 2014 - go.gale.com
Background Alzheimer's disease (AD) is the leading cause of dementia affecting greater
than 26 million people worldwide. Although cerebrospinal fluid (CSF) levels of A [beta]. sub …

[HTML][HTML] Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics

KR Wildsmith, SP Schauer, AM Smith… - Molecular …, 2014 - ncbi.nlm.nih.gov
Background Alzheimer's disease (AD) is the leading cause of dementia affecting greater
than 26 million people worldwide. Although cerebrospinal fluid (CSF) levels of Aβ 42, tau …

[HTML][HTML] Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics

KR Wildsmith, SP Schauer… - Molecular …, 2014 - molecularneurodegeneration …
Alzheimer's disease (AD) is the leading cause of dementia affecting greater than 26 million
people worldwide. Although cerebrospinal fluid (CSF) levels of Aβ42, tau, and p-tau181 are …

Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics

KR Wildsmith, SP Schauer, AM Smith… - Molecular …, 2014 - search.proquest.com
Alzheimer's disease (AD) is the leading cause of dementia affecting greater than 26 million
people worldwide. Although cerebrospinal fluid (CSF) levels of A [beta] 42, tau, and p …

Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics.

KR Wildsmith, SP Schauer, AM Smith… - Molecular …, 2014 - europepmc.org
Background Alzheimer's disease (AD) is the leading cause of dementia affecting greater
than 26 million people worldwide. Although cerebrospinal fluid (CSF) levels of Aβ42, tau …